CNTN5

CNTN5 (NB-2/contactin-5) is a neural cell recognition molecule of the contactin/immunoglobulin superfamily that organizes connectivity in the central auditory pathway and broader brain circuits (PMID:12653969, PMID:11438979). It is expressed in restricted regions including the cochlear nuclei, superior olive, inferior colliculi, medial geniculate nuclei, and auditory cortex, and within the auditory brainstem it is preferentially associated with glutamatergic neurons and glutamatergic synapses, with expression peaking during the final stages of synaptic maturation (PMID:11438979, PMID:19177518). Functionally, CNTN5 promotes neurite outgrowth in a cell-type-specific manner, supporting cortical but not hippocampal neurons (PMID:11438979), and it engages amyloid precursor-like protein 1 (APLP1) in a cis-complex on the presynaptic membrane (PMID:22285261). Loss of CNTN5 produces circuit-level dysfunction: knockout mice show aberrant acoustic responses and attenuated, mispatterned neuronal excitability in the inferior colliculus (PMID:12653969), and CNTN5-deficient human iPSC-derived glutamatergic neurons exhibit spontaneous network hyperactivity, linking loss of function to autism spectrum disorder phenotypes (PMID:30747104). The human gene maps to chromosome 11q21-q22.2 and produces long and short splice isoforms (PMID:11013081). Beyond these findings, the biochemical signaling downstream of CNTN5 and the structural basis of its interactions have not been characterized in the available corpus.

1. 2000 Medium

   Establishing the human gene's genomic location and isoform structure was the necessary first step toward connecting CNTN5 to brain function and disease.

   Evidence FISH chromosomal mapping and cDNA cloning of human NB-2/CNTN5, with brain expression analysis

   PMID:11013081

   Open questions at the time

   • No functional role assigned to the two isoforms
   • Tissue mapping limited to adult bulk regions, not cellular resolution
2. 2001 Medium

   Defining CNTN5 as a neurite-outgrowth-promoting molecule with cell-type specificity and a restricted auditory expression pattern gave the first mechanistic and anatomical clue to its role.

   Evidence In vitro neurite outgrowth assays on cortical vs hippocampal neurons plus in situ hybridization expression mapping in rat

   PMID:11438979

   Open questions at the time

   • Receptor or ligand mediating outgrowth not identified
   • Molecular basis of cortical vs hippocampal selectivity unknown
3. 2003 High

   Showing that CNTN5 loss disrupts auditory-evoked neuronal activity patterns established its requirement in vivo for normal auditory circuit function.

   Evidence NB-2 knockout mice with audiogenic seizure testing and c-Fos mapping in the inferior colliculus

   PMID:12653969

   Open questions at the time

   • Cellular mechanism linking CNTN5 loss to altered excitability not resolved
   • Whether the defect is synaptic, axonal, or developmental not distinguished
4. 2009 High

   Localizing CNTN5 specifically to glutamatergic neurons and synapses with a developmental expression peak refined its role to maturation of excitatory connectivity.

   Evidence Combined in situ hybridization/immunohistochemistry with VGLUT1/VGLUT2 colocalization and developmental profiling in auditory brainstem

   PMID:19177518

   Open questions at the time

   • Functional consequence of synaptic localization not tested directly
   • No molecular synaptic partner identified in this work
5. 2012 Medium

   Identifying the cis-complex with APLP1 on the presynaptic membrane provided the first direct molecular binding partner for CNTN5.

   Evidence Pull-down, cell surface binding, synapsin colocalization, and presynaptic fractionation in cultured neurons

   PMID:22285261

   Open questions at the time

   • Functional output of the CNTN5-APLP1 complex not established
   • Single lab; no in vivo confirmation of the interaction's role
6. 2019 Medium

   Demonstrating network hyperactivity in CNTN5-deficient human neurons connected loss of function to a defined electrophysiological phenotype relevant to autism spectrum disorder.

   Evidence iPSC-derived glutamatergic neurons from ASD patients with heterozygous CNTN5 variants, MEA and patch-clamp recordings

   PMID:30747104

   Open questions at the time

   • Molecular pathway linking CNTN5 loss to hyperactivity unknown
   • Heterozygous patient lines complicate isolation of CNTN5-specific effect

• The downstream signaling mechanism and structural basis by which CNTN5 controls neuronal excitability and synaptic maturation remain undefined.
• No intracellular signaling pathway identified for a GPI-anchored CNTN5
• Functional role of the APLP1 cis-complex not mechanistically tested
• No structural model of CNTN5 or its interactions